Ribociclib plus endocrine therapy in bone marrow visceral crisis: challenging the chemotherapy paradigm in luminal metastatic breast cancer—a case report
Oscar Ivan Pérez-López, Gonzalo Lendinez-Sanchez, Jesús González-García, Begoña Jiménez-Rodríguez, Myriam Leon-Fradejas, David Fernandez-Garay · 2025
Read Ribociclib plus endocrine therapy in bone marrow visceral crisis: challenging the chemotherapy paradigm in luminal metastatic breast cancer—a case report by Oscar Ivan Pérez-López, Gonzalo Lendinez-Sanchez, Jesús González-García, Begoña Jiménez-Rodríguez, Myriam Leon-Fradejas, David Fernandez-Garay (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12753461.txt.
Description
Oscar Ivan Perez-Lopez and co-authors report a breast cancer case that defied the standard playbook. Their 2025 case report describes a fifty-two-year-old woman whose hormone-driven, HER2-negative cancer had spread into her bone marrow. That spread counts as a visceral crisis, a state textbooks answer with chemotherapy because organs are failing fast.
Her blood counts had crashed from the marrow invasion. Care began with hormone therapy, then a targeted cell-cycle drug joined it. Counts and symptoms recovered quickly, and after nine cycles scans showed a complete metabolic response, with no major side effects. The authors argue marrow invasion broadens what visceral crisis means, and that hormone-based combos can rescue even these cases without chemotherapy's toll.
Catalog record
| CREATOR | Oscar Ivan Pérez-López, Gonzalo Lendinez-Sanchez, Jesús González-García, Begoña Jiménez-Rodríguez, Myriam Leon-Fradejas, David Fernandez-Garay |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |